ETSA winner Theranautilus heads to human trials; JSW One’s IPO plans

Happy Friday! Theranautilus is set to begin human trials of its nanorobot-based dental tech soon. This and more in today’s ETtech Morning Dispatch.

from Tech-Economic Times
via IFTTT